Related Experiment Video
Updated: Jun 10, 2026

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
Published on: September 28, 2022
Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral
Hisashi Iizasa1, Bjorn-Erik Wulff2, Nageswara R Alla2
1From the The Wistar Institute, Philadelphia, Pennsylvania 19104; Institute for Genetic Medicine, Hokkaido University, Sapporo 060-0815, Japan.
Abstract:
Certain primary transcripts of miRNA (pri-microRNAs) undergo RNA editing that converts adenosine to inosine. The Epstein-Barr virus (EBV) genome encodes multiple microRNA genes of its own. Here we report that primary transcripts of ebv-miR-BART6 (pri-miR-BART6) are edited in latently EBV-infected cells. Editing of wild-type pri-miR-BART6 RNAs dramatically reduced loading of miR-BART6-5p RNAs onto the microRNA-induced silencing complex. Editing of a mutation-containing pri-miR-BART6 found in Daudi Burkitt lymphoma and nasopharyngeal carcinoma C666-1 cell lines suppressed processing of miR-BART6 RNAs. Most importantly, miR-BART6-5p RNAs silence Dicer through multiple target sites located in the 3'-UTR of Dicer mRNA. The significance of miR-BART6 was further investigated in cells in various stages of latency. We found that miR-BART6-5p RNAs suppress the EBNA2 viral oncogene required for transition from immunologically less responsive type I and type II latency to the more immunoreactive type III latency as well as Zta and Rta viral proteins essential for lytic replication, revealing the regulatory function of miR-BART6 in EBV infection and latency. Mutation and A-to-I editing appear to be adaptive mechanisms that antagonize miR-BART6 activities.
Insights
Epstein-Barr virus (EBV) microRNAs are edited, affecting their function and viral latency. RNA editing and mutations antagonize EBV microRNA activity, impacting viral oncogene and replication protein suppression.
Area of Science:
- Molecular Biology
- Virology
- Epigenetics
Background:
- Primary microRNAs (pri-microRNAs) can undergo RNA editing, specifically adenosine to inosine conversion.
- The Epstein-Barr virus (EBV) genome encodes its own microRNA genes.
Purpose of the Study:
- To investigate RNA editing of EBV-encoded pri-miR-BART6 in latently infected cells.
- To determine the functional consequences of pri-miR-BART6 editing on miR-BART6 activity and EBV infection.
Main Methods:
- Analysis of pri-miR-BART6 RNA editing in EBV-infected cell lines.
- Assessment of microRNA loading onto the microRNA-induced silencing complex.
- Investigation of miR-BART6 target gene regulation (Dicer mRNA).
- Evaluation of miR-BART6-5p activity in different EBV latency stages.
Main Results:
- Pri-miR-BART6 RNAs are edited in latently EBV-infected cells.
- Editing of wild-type pri-miR-BART6 reduced miR-BART6-5p loading onto the silencing complex.
- Editing of mutated pri-miR-BART6 suppressed miR-BART6 processing.
- miR-BART6-5p silences Dicer mRNA and suppresses EBNA2, Zta, and Rta viral proteins.
- miR-BART6-5p activity is regulated during different EBV latency stages.
Conclusions:
- RNA editing and mutations in pri-miR-BART6 serve as adaptive mechanisms to antagonize miR-BART6 functions.
- miR-BART6 plays a regulatory role in EBV infection, latency, and replication.
- Understanding these mechanisms provides insights into EBV pathogenesis and viral control.
Related Concept Videos
Viruses with RNA Genomes
Inhibitors of Virion Maturation and Assembly
Inhibitors of Viral Protein Synthesis

